 |
PDBsum entry 1u5q
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of the tao2 kinase domain: activation and specifity of a ste20p map3k
|
|
Structure:
|
 |
Serine/threonine protein kinase tao2. Chain: a, b. Fragment: n-terminal kinase domain. Engineered: yes
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Gene: serine/threonine protein kinase tao2. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.223
|
R-free:
|
0.269
|
|
|
Authors:
|
 |
T.Zhou,M.Raman,Y.Gao,S.Earnest,Z.Chen,M.Machius,M.H.Cobb, E.J.Goldsmith
|
Key ref:
|
 |
T.Zhou
et al.
(2004).
Crystal structure of the TAO2 kinase domain: activation and specificity of a Ste20p MAP3K.
Structure,
12,
1891-1900.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
28-Jul-04
|
Release date:
|
12-Oct-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9JLS3
(TAOK2_RAT) -
Serine/threonine-protein kinase TAO2 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1235 a.a.
309 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Structure
12:1891-1900
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the TAO2 kinase domain: activation and specificity of a Ste20p MAP3K.
|
|
T.Zhou,
M.Raman,
Y.Gao,
S.Earnest,
Z.Chen,
M.Machius,
M.H.Cobb,
E.J.Goldsmith.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
TAO2 is a mitogen-activated protein kinase kinase kinase (MAP3K) that doubly
phosphorylates and activates the MAP kinase kinases (MAP2Ks) MEK3 and MEK6. The
structure of the kinase domain of TAO2 (1-320) has been solved in its
phosphorylated active conformation. The structure, together with structure-based
mutagenic analysis, reveals that positively charged residues in the substrate
binding groove mediate the first step in the dual phosphorylation of MEK6, on
the threonine residue in the motif DS*VAKT*I (*denotes phosphorylation site) of
MEK6. TAO2 is a Ste20p homolog, and the structure of active TAO2, in comparison
with that of low-activity p21-activated protein kinase (PAK1), a Ste20p-related
MAP4K, reveals how this group of kinases is activated by phosphorylation.
Finally, active TAO2 displays unusual interactions with ATP, involving, in part,
a subgroup-specific C-terminal extension of TAO2. The observed interactions may
be useful in making specific inhibitors of TAO kinases.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 1.
Figure 1. Overall Structure and Electron Density of TAO2
Kinase Domain(A) Ribbon diagram of TAO2 (1-320) in complex with
MgATP. Phosphate binding ribbon is colored yellow, catalytic
loop is orange, and activation loop is pink. b strands are
green, conserved helices are blue, and additional helices are
purple (aA and aB) or magenta (aJ and aK). pSer181 and MgATP
molecules are shown in ball-and-stick representation.(B)
Electron density of apo-TAO2 in the vicinity of the pSer181 and
the P+1 pocket, contoured at 1.0 s and drawn on O (Jones et al.,
1991). Phosphate atom is green, and ordered water molecules are
red spheres. Figure 1, Figure 3, Figure 4, Figure 5 and Figure 6
were prepared using Molscript (Kraulis, 1991) and rendered using
POV-Ray (Persistence of Vision Ray Tracer v3.1g, POV-Team).
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2004,
12,
1891-1900)
copyright 2004.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.Zhou,
L.Commodore,
W.S.Huang,
Y.Wang,
T.K.Sawyer,
W.C.Shakespeare,
T.Clackson,
X.Zhu,
and
D.C.Dalgarno
(2010).
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template.
|
| |
Chem Biol Drug Des,
75,
18-28.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Delpire
(2009).
The mammalian family of sterile 20p-like protein kinases.
|
| |
Pflugers Arch,
458,
953-967.
|
 |
|
|
|
|
 |
E.Zeqiraj,
B.M.Filippi,
S.Goldie,
I.Navratilova,
J.Boudeau,
M.Deak,
D.R.Alessi,
and
D.M.van Aalten
(2009).
ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor.
|
| |
PLoS Biol,
7,
e1000126.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.A.Falin,
R.Morrison,
A.J.Ham,
and
K.Strange
(2009).
Identification of regulatory phosphorylation sites in a cell volume- and Ste20 kinase-dependent ClC anion channel.
|
| |
J Gen Physiol,
133,
29-42.
|
 |
|
|
|
|
 |
R.Anand,
J.Maksimoska,
N.Pagano,
E.Y.Wong,
P.A.Gimotty,
S.L.Diamond,
E.Meggers,
and
R.Marmorstein
(2009).
Toward the development of a potent and selective organoruthenium mammalian sterile 20 kinase inhibitor.
|
| |
J Med Chem,
52,
1602-1611.
|
 |
|
|
|
|
 |
S.J.Lee,
M.H.Cobb,
and
E.J.Goldsmith
(2009).
Crystal structure of domain-swapped STE20 OSR1 kinase domain.
|
| |
Protein Sci,
18,
304-313.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Liu,
and
R.B.Altman
(2009).
Prediction of calcium-binding sites by combining loop-modeling with machine learning.
|
| |
BMC Struct Biol,
9,
72.
|
 |
|
|
|
|
 |
W.Wang,
Y.Yang,
Y.Gao,
Q.Xu,
F.Wang,
S.Zhu,
W.Old,
K.Resing,
N.Ahn,
M.Lei,
and
X.Liu
(2009).
Structural and mechanistic insights into Mps1 kinase activation.
|
| |
J Cell Mol Med,
13,
1679-1694.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Min,
R.Akella,
H.He,
J.M.Humphreys,
S.E.Tsutakawa,
S.J.Lee,
J.A.Tainer,
M.H.Cobb,
and
E.J.Goldsmith
(2009).
The structure of the MAP2K MEK6 reveals an autoinhibitory dimer.
|
| |
Structure,
17,
96.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Merckx,
A.Echalier,
K.Langford,
A.Sicard,
G.Langsley,
J.Joore,
C.Doerig,
M.Noble,
and
J.Endicott
(2008).
Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design.
|
| |
Structure,
16,
228-238.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Villa,
M.Deak,
D.R.Alessi,
and
D.M.van Aalten
(2008).
Structure of the OSR1 kinase, a hypertension drug target.
|
| |
Proteins,
73,
1082-1087.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Eswaran,
M.Soundararajan,
R.Kumar,
and
S.Knapp
(2008).
UnPAKing the class differences among p21-activated kinases.
|
| |
Trends Biochem Sci,
33,
394-403.
|
 |
|
|
|
|
 |
J.Kang,
M.Yang,
B.Li,
W.Qi,
C.Zhang,
K.M.Shokat,
D.R.Tomchick,
M.Machius,
and
H.Yu
(2008).
Structure and substrate recruitment of the human spindle checkpoint kinase Bub1.
|
| |
Mol Cell,
32,
394-405.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Doerig,
and
L.Meijer
(2007).
Antimalarial drug discovery: targeting protein kinases.
|
| |
Expert Opin Ther Targets,
11,
279-290.
|
 |
|
|
|
|
 |
J.D.Knight,
B.Qian,
D.Baker,
and
R.Kothary
(2007).
Conservation, variability and the modeling of active protein kinases.
|
| |
PLoS ONE,
2,
e982.
|
 |
|
|
|
|
 |
J.Eswaran,
W.H.Lee,
J.E.Debreczeni,
P.Filippakopoulos,
A.Turnbull,
O.Fedorov,
S.W.Deacon,
J.R.Peterson,
and
S.Knapp
(2007).
Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs.
|
| |
Structure,
15,
201-213.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Zihni,
C.Mitsopoulos,
I.A.Tavares,
A.J.Ridley,
and
J.D.Morris
(2006).
Prostate-derived sterile 20-like kinase 2 (PSK2) regulates apoptotic morphology via C-Jun N-terminal kinase and Rho kinase-1.
|
| |
J Biol Chem,
281,
7317-7323.
|
 |
|
|
|
|
 |
K.B.Gagnon,
R.England,
and
E.Delpire
(2006).
Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter.
|
| |
Mol Cell Biol,
26,
689-698.
|
 |
|
|
|
|
 |
T.J.Zhou,
L.G.Sun,
Y.Gao,
and
E.J.Goldsmith
(2006).
Crystal structure of the MAP3K TAO2 kinase domain bound by an inhibitor staurosporine.
|
| |
Acta Biochim Biophys Sin (Shanghai),
38,
385-392.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Lei,
M.A.Robinson,
and
S.C.Harrison
(2005).
The active conformation of the PAK1 kinase domain.
|
| |
Structure,
13,
769-778.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Du,
B.C.Böck,
K.A.Schachter,
M.Chao,
and
K.A.Gallo
(2005).
Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3.
|
| |
J Biol Chem,
280,
42984-42993.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |